EPHX2 and cardiac hypertrophy: We and others reported that sEH inhibition relieved angiotensin II (AngII)-induced hypertension [26] and cardiac hypertrophy [27] and protected against apoptosis of pancreatic islet cells with streptozotocin-induced diabetes [28].